Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T17:57:50.358Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:57:50.358Z.

Quote observation: 2026-10-06T17:52:27.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 63,158,604
TTM free cash flow · period ending 2026-06-30: -70,895,000

FMP input reference: e1640542559587d997c0d8eaeaaf8c892bebef217736e9d4e66575bab6404537

P/E Ratio|FCF Growth|Operating Margin|All Metrics

PLRX Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

PRICE/FCF RATIO AVG TTM

N/A

PRICE/FCF RATIO AVG 3Y

N/A

PRICE/FCF RATIO AVG 5Y

N/A

PRICE/FCF RATIO AVG 10Y

N/A

PRICE/FCF RATIO AVG 15Y

N/A

PRICE/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

PLRX Competitors' Price/FCF Ratio

PLRX

Pliant Therapeutics, Inc.

Current

Market Cap

$63.16M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALPS

Alps Group Inc

vs PLRX

Market Cap

$63.25M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HRTX

Heron Therapeutics, Inc.

vs PLRX

Market Cap

$63.92M

Price/FCF Ratio

N/A

TTM Avg

1.90

3Y Avg

1.90

5Y Avg

1.90

GUTS

Fractyl Health, Inc.

vs PLRX

Market Cap

$61.54M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INCR

InterCure Ltd.

vs PLRX

Market Cap

$63.14M

Price/FCF Ratio

8.59

TTM Avg

6.78

3Y Avg

6.78

5Y Avg

131.43

RNXT

RenovoRx, Inc.

vs PLRX

Market Cap

$64.43M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOSS

Gossamer Bio, Inc.

vs PLRX

Market Cap

$64.41M

Price/FCF Ratio

N/A

TTM Avg

35.77

3Y Avg

35.77

5Y Avg

35.77

KLRS

Kalaris Therapeutics Inc

vs PLRX

Market Cap

$61.44M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONCY

Oncolytics Biotech Inc.

vs PLRX

Market Cap

$60.21M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CING

Cingulate Inc.

vs PLRX

Market Cap

$66.20M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Pliant Therapeutics, Inc. (PLRX)	$63.16M	N/A	N/A	N/A	N/A
Alps Group Inc (ALPS)vs ›	$63.25M	N/A	N/A	N/A	N/A
Heron Therapeutics, Inc. (HRTX)vs ›	$63.92M	N/A	1.90	1.90	1.90
Fractyl Health, Inc. (GUTS)vs ›	$61.54M	N/A	N/A	N/A	N/A
InterCure Ltd. (INCR)vs ›	$63.14M	8.59	6.78	6.78	131.43
RenovoRx, Inc. (RNXT)vs ›	$64.43M	N/A	N/A	N/A	N/A
Gossamer Bio, Inc. (GOSS)vs ›	$64.41M	N/A	35.77	35.77	35.77
Kalaris Therapeutics Inc (KLRS)vs ›	$61.44M	N/A	N/A	N/A	N/A
Oncolytics Biotech Inc. (ONCY)vs ›	$60.21M	N/A	N/A	N/A	N/A
Cingulate Inc. (CING)vs ›	$66.20M	N/A	N/A	N/A	N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PLRX Price/FCF Ratio History

DATE	PRICE/FCF RATIO
2021-03-16	92.03
2021-03-15	91.38
2021-03-12	90.97
2021-03-11	91.43
2021-03-10	91.19
2021-03-09	91.12
2021-03-08	82.11
2021-03-05	75.32
2021-03-04	76.82
2021-03-03	86.05
2021-03-02	87.91
2021-03-01	84.78
2021-02-26	79.09
2021-02-25	94.99
2021-02-24	95.75
2021-02-23	81.58
2021-02-22	83.56
2021-02-19	79.26
2021-02-18	72.59
2021-02-17	76.42
2021-02-16	78.64
2021-02-12	74.86
2021-02-11	71.40
2021-02-10	69.15
2021-02-09	76.75
2021-02-08	74.94
2021-02-05	81.51
2021-02-04	74.84
2021-02-03	73.55
2021-02-02	73.36
2021-02-01	60.50
2021-01-29	58.82
2021-01-28	59.95
2021-01-27	62.51
2021-01-26	64.68
2021-01-25	65.14
2021-01-22	63.34
2021-01-21	62.34
2021-01-20	60.83
2021-01-19	62.82
2021-01-15	62.46
2021-01-14	61.86
2021-01-13	66.21
2021-01-12	66.23
2021-01-11	65.64
2021-01-08	65.57
2021-01-07	66.04
2021-01-06	65.42
2021-01-05	59.61
2021-01-04	58.61
2020-12-31	54.31
2020-12-30	55.77
2020-12-29	59.02
2020-12-28	60.14
2020-12-24	60.74
2020-12-23	61.29
2020-12-22	62.70
2020-12-21	60.81
2020-12-18	60.93
2020-12-17	64.49
2020-12-16	65.95
2020-12-15	68.82
2020-12-14	65.54
2020-12-11	63.68
2020-12-10	65.23
2020-12-09	62.72
2020-12-08	66.12
2020-12-07	64.97
2020-12-04	67.41
2020-12-03	67.55
2020-12-02	68.12
2020-12-01	71.71
2020-11-30	65.78
2020-11-27	78.86
2020-11-25	71.16
2020-11-24	70.35
2020-11-23	68.96
2020-11-20	68.41
2020-11-19	65.42
2020-11-18	62.82
2020-11-17	69.25
2020-11-16	62.77
2020-11-13	59.18
2020-11-12	61.45
2020-11-11	60.33
2020-11-10	18.03
2020-11-09	17.23
2020-11-06	16.71
2020-11-05	17.26
2020-11-04	16.74
2020-11-03	16.35
2020-11-02	16.19
2020-10-30	16.54
2020-10-29	16.47
2020-10-28	15.91
2020-10-27	16.95
2020-10-26	17.38
2020-10-23	18.18
2020-10-22	17.65
2020-10-21	17.49
2020-10-20	17.45
2020-10-19	18.56
2020-10-16	19.01
2020-10-15	18.55
2020-10-14	18.02
2020-10-13	18.76
2020-10-12	19.02
2020-10-09	18.60
2020-10-08	18.04
2020-10-07	18.63
2020-10-06	16.77
2020-10-05	16.39
2020-10-02	15.37
2020-10-01	15.21
2020-09-30	17.33
2020-09-29	18.16
2020-09-28	17.24
2020-09-25	16.48
2020-09-24	17.15
2020-09-23	16.88
2020-09-22	17.99
2020-09-21	18.27
2020-09-18	21.58
2020-09-17	21.13
2020-09-16	21.00
2020-09-15	19.88
2020-09-14	21.02
2020-09-11	20.06
2020-09-10	20.06
2020-09-09	19.04
2020-09-08	18.51
2020-09-04	17.81
2020-09-03	18.60
2020-09-02	18.75
2020-09-01	19.13
2020-08-31	19.24
2020-08-28	19.88
2020-08-27	18.66
2020-08-26	18.79
2020-08-25	18.71
2020-08-24	18.70
2020-08-21	19.26
2020-08-20	19.42
2020-08-19	18.82
2020-08-18	18.85
2020-08-17	18.94
2020-08-14	18.64
2020-08-13	18.74
2020-08-12	18.58

Price/FCF Ratio: N/A

PLRX Price/FCF Ratio Chart

PLRX Price/FCF Ratio Metrics

PLRX Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

PLRX Price/FCF Ratio History

Related Metrics